OctoPlus N.V.
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
01 feb 2012 - 22:19
Statutory name
OctoPlus N.V.
Title
OctoPlus enters into drug development and manufacturing contract with Ferring Pharmaceuticals A/S
Comments
OctoPlus N.V. (“OctoPlus” or the “Company”) (Euronext: OCTO), announces today that a formulation development and manufacturing contract has been signed with Ferring Pharmaceuticals A/S, a leading innovative pharmaceutical company. The undisclosed contract value will make a material contribution to OctoPlus’ 2012 revenues. Further details on the compound and activities are not disclosed.
Date last update: 30 October 2026